Treating lung cancer cells with BSP inhibited the protein and mRNA expression of E‐cadherin and promoted vimentin expression (Figure 1E–H), whereas inhibiting BSP expression had the opposite effects (Figure 1J–L). This evidence concerns the gene CDH1 and lung carcinoma.